Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease characterized by chronic inflammation of the airways and obstruction of airflow in and out of the lungs. It is a term used to describe a group of lung conditions, including chronic bronchitis, emphysema, and alpha-1 antitrypsin deficiency.
Here are some key features and information about COPD:
COPD is a serious condition that can significantly reduce a person's quality of life and may lead to severe complications if left untreated. Therefore, it's important for individuals at risk (e.g., smokers and those with a history of exposure to lung irritants) to seek medical attention and follow recommended treatments and lifestyle changes to manage the disease.
Testing for COPD
There are several tests that can be used to diagnose chronic obstructive pulmonary disease (COPD), including:
A combination of tests may be used to confirm the diagnosis of COPD. Your doctor will also take into account your symptoms and medical history to determine the best course of action.
Pulmonary rehabilitation is a program of exercise and education that can help people with COPD manage their symptoms, improve their physical fitness, and increase their ability to perform daily activities. Some specific benefits of pulmonary rehab for people with COPD include:
It's important to note that pulmonary rehabilitation is tailored to the individual needs of the patient and can vary depending on the stage and severity of the disease, and the person's overall physical condition.
Common vaccinations for people with stable COPD
Common vaccines recommended for people with stable chronic obstructive pulmonary disease (COPD) include: High-dose influenza (flu) vaccine, pneumococcal vaccine, respiratory syncytial virus (RSV) vaccine and less frequently the tetanus, diphtheria, and pertussis (Tdap) vaccine. It's important to note that vaccine recommendations may be updated over time as individual health conditions can vary. Therefore, it's best to consult with a healthcare provider to determine the most appropriate vaccination schedule for someone with COPD. Your healthcare provider will make recommendations based on your health status and will make adjustments if there are changes to federal vaccine guidelines.
Older Canadians suffer disproportionately from flu-related morbidity and mortality. Adults 65+ represent 15% of the Canadian population. However, during influenza season they account for 70% of the hospitalizations. Complications of influenza often result in COPD exacerbations which can then trigger heart attacks and stroke. Influenza vaccination can reduce serious illness such as lower respiratory tract infections. Vaccines containing either killed or live inactivated viruses are recommended as they are more effective in elderly people with COPD. Studies suggest that people with COPD, particularly the elderly, had decreased risk of ischemic heart disease when they were vaccinated with the high-dose influenza vaccine. Learn more: www.copdcanada.info/influenza-myths-and-facts/
Pneumonia is caused by an infection in the lungs. The infection affects the air sacs in the lungs rather than the tubes that carry air to and from the lungs. Infected parts of the lung fill up with fluid, which contains white blood cells that fight the infection. Pneumonia is caused by germs (tiny organisms that can cause disease). Viruses, bacteria and fungi are types of germ that can cause pneumonia. Pneumococcal vaccinations, pneumococcal conjugated vaccine (PCV20 or PCV15) and pneumococcal polysaccharide vaccine (PPSV23), are approved for adults 65 years and older. They are also approved for adults aged 19-64 years if they have an underlying medical condition such as chronic lung disease (including COPD, emphysema, and asthma), a history of cigarette smoking or have undergone a solid organ transplant. Pneumococcal vaccination is universally recommended for adults in these age groups. Learn more: www.copdcanada.info/pneumonia/
Respiratory syncytial virus (RSV) vaccines
Respiratory syncytial virus (RSV) is a common respiratory virus that can cause severe illness in individuals with chronic obstructive pulmonary disease (COPD). RSV primarily affects the lungs and respiratory tract, leading to symptoms such as coughing, wheezing, and shortness of breath. In individuals with COPD, RSV infection can exacerbate existing respiratory issues and potentially lead to serious complications. One effective way to prevent RSV infection in individuals with COPD is through vaccination. The RSV vaccine can help to reduce the risk of developing severe respiratory complications associated with the virus. Learn more: www.rsvandme.ca/older-adults
Tetanus, diphtheria, and pertussis (whooping cough) are preventable through the Tdap vaccine. Adults are recommended to receive a Tdap vaccine once, followed by a Td (tetanus and diphtheria) booster every 10 years. Learn more: https://tinyurl.com/yzdx6hw3
COPD is divided into stages
People living with COPD are assigned a stage according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) system. The GOLD system includes four distinct stages of COPD, they are:
These stages are assigned based on the results of a spirometry test. This is a simple test that is usually performed in a doctor’s office. To take the test, you breathe in as deeply as possible and then exhale into a tool called a spirometer. Your doctor will measure your forced expiratory volume in 1 second (FEV1). In simple terms, this is how much air you push out within 1 second. They will then calculate the percentage difference between your actual FEV1 score and the predicted value (how much air you should be able to push out, based on your age, height, and weight to help determine a stage for your COPD.
In general, the lower your FEV1 percentage score, the higher (worse) your COPD stage is.
The results of your test will help determine your stage.
We need your consent to load the translations
We use a third-party service to translate the website content that may collect data about your activity. Please review the details and accept the service to view the translations.